- Open
- 1.77
- High
- 1.85
- Low
- 1.70
- Close
- 1.77
- Change
- -0.07 (-4.23%)
- Volume
- 4,780,212
⌘K
| 29 May 2026 | 07:00:03 | MSA with Global Pharmaceutical Company |
| 18 May 2026 | 07:00:07 | Collaboration with AdventHealth for two studies |
| 11 May 2026 | 07:00:10 | Q1 trading update and outlook for 2026 |
| 30 Apr 2026 | 07:00:10 | Confirmation of Q1 trading update |
| 29 May 2026 | 07:00:03 | MSA with Global Pharmaceutical Company |
| 18 May 2026 | 07:00:07 | Collaboration with AdventHealth for two studies |
| 11 May 2026 | 07:00:10 | Q1 trading update and outlook for 2026 |
| 30 Apr 2026 | 07:00:10 | Confirmation of Q1 trading update |
| 20 Apr 2026 | 07:00:07 | Research Collaboration with The Royal Marsden |
| 29 May 2026 |
| CelLBxHealth shares soar after inking agreement with AstraZeneca |
| 29 May 2026 | CelLBxHealth shares jump 36% after master services agreement with AstraZeneca |
| 29 May 2026 | CelLBxHealth signs master services agreement with AstraZeneca |
| 24 May 2026 | AIM weekly movers: CelLBxHealth collaboration |
| 11 May 2026 | AIM movers: Nativo Resources exploration target and Fusion Antibodies patent grant |
| 20 Apr 2026 | 07:00:07 | Research Collaboration with The Royal Marsden |
| 29 May 2026 |
| CelLBxHealth shares soar after inking agreement with AstraZeneca |
| 29 May 2026 | CelLBxHealth shares jump 36% after master services agreement with AstraZeneca |
| 29 May 2026 | CelLBxHealth signs master services agreement with AstraZeneca |
| 24 May 2026 | AIM weekly movers: CelLBxHealth collaboration |
| 11 May 2026 | AIM movers: Nativo Resources exploration target and Fusion Antibodies patent grant |
